Interest in thalidomide (Thalomid) has intensified in recent years as research has identified and elucidated its immunomodulatory, anti-inflammatory, and antiangiogenic properties. In this supplement, we present a selection of abstracts
Mohamad A. Hussein, MD
Advertisement
Articles by Mohamad A. Hussein, MD
Advertisement
Latest Updated Articles
- Research on Thalidomide in Solid Tumors, Hematologic Malignancies, and Supportive Care
Published: November 1st 2000 | Updated:
Advertisement
Advertisement
Trending on CancerNetwork
1
How Will Gastrointestinal Cancer Standards of Care Change? An ESMO Recap
2
Sac-TMT Combo Produces Encouraging Activity in Pretreated Metastatic CRPC
3
Zurletrectinib Generates Responses in Advanced NTRK Fusion Solid Tumors
4
Atezolizumab Combo Elicits No Significant Benefit in Ovarian Cancer
5
